Management of a pregnant patient with chylomicronemia from a novel mutation in GPIHBP1: a case report.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
06 May 2020
Historique:
received: 14 01 2020
accepted: 22 04 2020
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 26 1 2021
Statut: epublish

Résumé

Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive lipid disorder often associated with recurrent episodes of pancreatitis. It is documented in most cases with FCS due to the mutations of key proteins in lipolysis, including LPL, APOC2, APOA5, LMF1 and GPIHBP1. We report the successful management of a 35-year-old pregnant woman carrying a novel homozygous frameshift mutation c.48_49insGCGG (p.P17A fs*22) in the GPIHBP1 gene with previous severe episodes of acute pancreatitis triggered by pregnancy, resulting in adverse obstetrical outcomes. With careful monitoring, the patient underwent an uneventful pregnancy and delivered a baby with no anomalies. The case report contributes to the understanding of GPIHBP1-deficient familial chylomicronemia syndrome (FCS) and highlights gestational management of FCS patient.

Sections du résumé

BACKGROUND BACKGROUND
Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive lipid disorder often associated with recurrent episodes of pancreatitis. It is documented in most cases with FCS due to the mutations of key proteins in lipolysis, including LPL, APOC2, APOA5, LMF1 and GPIHBP1.
CASE PRESENTATION METHODS
We report the successful management of a 35-year-old pregnant woman carrying a novel homozygous frameshift mutation c.48_49insGCGG (p.P17A fs*22) in the GPIHBP1 gene with previous severe episodes of acute pancreatitis triggered by pregnancy, resulting in adverse obstetrical outcomes. With careful monitoring, the patient underwent an uneventful pregnancy and delivered a baby with no anomalies.
CONCLUSIONS CONCLUSIONS
The case report contributes to the understanding of GPIHBP1-deficient familial chylomicronemia syndrome (FCS) and highlights gestational management of FCS patient.

Identifiants

pubmed: 32375710
doi: 10.1186/s12884-020-02965-1
pii: 10.1186/s12884-020-02965-1
pmc: PMC7201967
doi:

Substances chimiques

GPIHBP1 protein, human 0
Receptors, Lipoprotein 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

272

Références

J Clin Endocrinol Metab. 2012 Sep;97(9):2969-89
pubmed: 22962670
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):90-94
pubmed: 30198520
Med Sci Monit. 2018 Aug 13;24:5619-5623
pubmed: 30100601
Endocrine. 2002 Oct;19(1):43-55
pubmed: 12583601
Am J Hum Genet. 2011 Apr 8;88(4):440-9
pubmed: 21457909
J Biol Chem. 2003 Feb 28;278(9):7344-9
pubmed: 12496272
Cell Metab. 2007 Apr;5(4):279-91
pubmed: 17403372
Circulation. 2011 May 24;123(20):2292-333
pubmed: 21502576
J Clin Invest. 1995 Dec;96(6):2555-68
pubmed: 8675619
Endocr Pract. 2017 Apr 2;23(4):479-497
pubmed: 28156151
Obstet Gynecol. 2011 Feb;117(2 Pt 2):517-9
pubmed: 21252809
J Clin Endocrinol Metab. 2012 Aug;97(8):2589-96
pubmed: 22639290
Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:226-7
pubmed: 27095069
Nat Rev Endocrinol. 2015 Jun;11(6):352-62
pubmed: 25732519
Reprod Sci. 2009 May;16(5):431-7
pubmed: 19233944
Ultrasound Obstet Gynecol. 2008 Mar;31(3):321-7
pubmed: 18241086
Lipids Health Dis. 2018 Apr 11;17(1):78
pubmed: 29642923
Trends Endocrinol Metab. 2016 Jul;27(7):455-469
pubmed: 27185325
Adv Intern Med. 1969;15:117-54
pubmed: 4908616
Curr Opin Lipidol. 2011 Aug;22(4):247-53
pubmed: 21519249
N Engl J Med. 2017 Apr 27;376(17):1647-1658
pubmed: 28402248
Endocr Pract. 2018 Aug;24(8):756-763
pubmed: 30183397
Clin Chem Lab Med. 2014 Dec;52(12):1695-727
pubmed: 23940067
Obstet Med. 2015 Dec;8(4):158-67
pubmed: 27512474
BMC Pregnancy Childbirth. 2004 Dec 20;4(1):27
pubmed: 15610556
J Atheroscler Thromb. 2013;20(10):777-84
pubmed: 23831619
Circ Res. 2015 Feb 13;116(4):624-32
pubmed: 25387803
J Lipid Res. 2011 Nov;52(11):1869-84
pubmed: 21844202

Auteurs

Min-Huan Lin (MH)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Xiao-Hui Tian (XH)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Xiu-Lan Hao (XL)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Hui Fei (H)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Jian-Lan Yin (JL)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Dan-Dan Yan (DD)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China.

Tian Li (T)

Department of Obstetrics & Gynecology, the Seventh Affiliated Hospital of Sun Yat-Sen University, 628 Zhenyuan Road, Guangming District, Shenzhen, China. litianlucky@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH